Kee Lung Hong
Presidente en TAIWAN LIPOSOME COMPANY, LTD. .
Cargos activos de Kee Lung Hong
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| TAIWAN LIPOSOME COMPANY, LTD. | Presidente | 27/06/2003 | - |
| Director Ejecutivo | 05/05/2009 | - | |
| Fundador | 10/11/1997 | - | |
| TLC Biopharmaceuticals, Inc. | Director Ejecutivo | - | - |
| Presidente | - | - |
Historial de carrera de Kee Lung Hong
Antiguos cargos conocidos de Kee Lung Hong.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| California Pacific Medical Center Research Institute | Corporate Officer/Principal | 01/01/1979 | 01/01/2002 |
Hermes Biosciences, Inc.
 Hermes Biosciences, Inc. BiotechnologyHealth Technology Hermes Biosciences, Inc. develops innovative targeted drug delivery technologies for therapeutic and other biomedical applications. The company was founded by John W. Park, James D. Marks, Keelung Hong and Christopher Benz and is headquartered in South San Francisco, CA. | Fundador | - | - |
SEQUUS Pharmaceuticals, Inc.
 SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SEQUUS Pharmaceuticals, Inc. is based in Menlo Park, CA. Part of Johnson & Johnson, SEQUUS Pharmaceuticals, Inc. is a company that markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases. SEQUUS Pharmaceuticals was acquired by ALZA Corp., part of Johnson & Johnson from June 22, 2001 on March 16, 1999 for $658.03 million. | Corporate Officer/Principal | - | - |
Fougera Pharmaceuticals, Inc.
 Fougera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fougera Pharmaceuticals, Inc. develops and manufactures specialty pharmaceuticals in dermatology. It operates through two core divisions: PharmaDerm and Fougera. The PharmaDerm division offers in-house expertise and facilities for formulation development, clinical development, manufacturing, distribution, and sales and marketing. The company was founded in 1849 and is headquartered in Melville, NY. | Corporate Officer/Principal | - | - |
| Salutar, Inc. | Corporate Officer/Principal | - | - |
Formación de Kee Lung Hong.
| National Cheng Kung University | Undergraduate Degree |
| The University of Texas at Austin | Graduate Degree |
| University of California, Berkeley | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 9 |
| Taiwán | 3 |
Operativa
| Corporate Officer/Principal | 4 |
| Chief Executive Officer | 2 |
| Chairman | 2 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
Taiwan Liposome Co., Ltd.
 Taiwan Liposome Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiwan Liposome Co., Ltd. engages in the research and development of lipid-based formulation drugs. Its products are used for pain management, eye disease treatment, and cancer treatment. The company was founded by Kee Lung Hong on November 10, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
| Salutar, Inc. | |
SEQUUS Pharmaceuticals, Inc.
SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SEQUUS Pharmaceuticals, Inc. is based in Menlo Park, CA. Part of Johnson & Johnson, SEQUUS Pharmaceuticals, Inc. is a company that markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases. SEQUUS Pharmaceuticals was acquired by ALZA Corp., part of Johnson & Johnson from June 22, 2001 on March 16, 1999 for $658.03 million. | Health Technology |
Fougera Pharmaceuticals, Inc.
Fougera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fougera Pharmaceuticals, Inc. develops and manufactures specialty pharmaceuticals in dermatology. It operates through two core divisions: PharmaDerm and Fougera. The PharmaDerm division offers in-house expertise and facilities for formulation development, clinical development, manufacturing, distribution, and sales and marketing. The company was founded in 1849 and is headquartered in Melville, NY. | Health Technology |
| TLC Biopharmaceuticals, Inc. | |
Hermes Biosciences, Inc.
Hermes Biosciences, Inc. BiotechnologyHealth Technology Hermes Biosciences, Inc. develops innovative targeted drug delivery technologies for therapeutic and other biomedical applications. The company was founded by John W. Park, James D. Marks, Keelung Hong and Christopher Benz and is headquartered in South San Francisco, CA. | Health Technology |
| California Pacific Medical Center Research Institute |
- Bolsa de valores
- Insiders
- Kee Lung Hong
- Experiencia
